WinfredC.WangMD
Pediatric Hematology & Oncology • Memphis, TNProfessor of Pediatrics, University Tenn College of Medicine
Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
262 Danny Thomas Pl
Memphis, TN 38105Phone+1 901-595-3497Fax+1 901-595-3842- Is this information wrong?
Education & Training
University of California (San Francisco)Residency, Pediatrics, 1974 - 1974- University of California (San Francisco)Residency, Internal Medicine, 1972 - 1973
University of HawaiiResidency, Pediatrics, 1969 - 1970
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1967 - 1969
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1967
Certifications & Licensure
TN State Medical License 1979 - 2018
MS State Medical License Active through 2013- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- Memphis Magazine: Top Doctors Castle Connolly, 2006, 2010-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2006, 2010-2013
Clinical Trials
- Penicillin Prophylaxis in Sickle Cell Disease (PROPS) Start of enrollment: 1983 Aug 01
- Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia Start of enrollment: 2000 Aug 01
- Use of Hydroxyurea and Magnesium Pidolate for Treatment of Sickle Cell Disease Start of enrollment: 2004 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Intensive hydroxyurea dosing in very young children with sickle cell anemia.Winfred C Wang, R Clark Brown, Melissa A McNaull, Zora R Rogers, Martha Barton, Meghna R Dua, Jane S Hankins, Jeffrey Gossett, Julie Richardson, Jerlym S Porter, Guoli...> ;Blood Advances. 2023 Nov 28
- Hydroxyurea maintains working memory function in pediatric sickle cell disease.Lai, J., Zou, P., Dalboni da Rocha, J., Heitzer, A., Patni, T., Li, Y., Scoggins, M., Sharma, A., Sitaram, R., Wang, W., Helton, K.> ;Medrxiv. 2023 Nov 23
- Catechol-O-methyltransferase gene (COMT) is associated with neurocognitive functioning in patients with sickle cell disease.Heitzer, A., Rashkin, S., Trpchevska, A., Longoria, J., Rampersaud, E., Olufadi, Y., Raches, D., Potter, B., Steinberg, M., King, A., Kang, G., Wang, W., Takemoto, C.,...> ;Current Research in Translational Medicine. 2023 Nov 21
- Join now to see all
Abstracts/Posters
- Neurocognitive Impairment Predicts Poor Transition Outcomes Among Patients with Sickle Cell DiseaseWinfred Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Transcranial Doppler Velocities Conversion Rate Based on Increasing Hemoglobin Concentration: Analysis from the SCCRIP Cohort StudyWinfred Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Progression of Central Nervous System Vasculopathy in Young Adults with Sickle Cell AnemiaWinfred Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
2017 American Society of Hematology (ASH) MeetingDecember 11th, 2018
Sickle Cell Anemia Drug Safe and Effective for Infants and Toddlers, Adds Treatment Option, Study SuggestsJune 14th, 2011
Drug Treatment Means Better, Less Costly Care for Children with Sickle Cell DiseaseFebruary 10th, 2016- Join now to see all
Grant Support
- Treatment With Hydroxyurea And Magnesium:A Prospective Phase III Clinical TrialNational Heart, Lung, And Blood Institute2004–2007
- Sickle Cell Scholar'S ProgramNational Heart, Lung, And Blood Institute2003–2007
- Comprehensive Sickle Cell CenterNational Heart, Lung, And Blood Institute2003–2007
- Combination Treatment With Hydroxyurea And Magnesium: Phase I &Phase II StudiesNational Heart, Lung, And Blood Institute2003–2007
- Combination Treatment With Hydroxyurea And Magnesium:A Prospective Randomized DouNational Heart, Lung, And Blood Institute2003
- Administrative CoreNational Heart, Lung, And Blood Institute2003
- Pedriatric Hydroxyurea Phase III Clinical Trial ClinicalDivision Of Blood Diseases And Resources2000–2001
- Pediatric Cohort Of The CsscdDivision Of Blood Diseases And Resources1994–1998
- Selected Patient Groups From The CsscdDivision Of Blood Diseases And Resources1994
- Investigation Of Selected Patient Groups From The CsscdDivision Of Blood Diseases And Resources1989–1993
- Prophylactic Penicillin In Sickle Cell DiseaseDivision Of Blood Diseases And Resources1987–1993
Hospital Affiliations
St. Jude Children's Research HospitalMemphis, Tennessee
Methodist Healthcare Memphis HospitalsMemphis, Tennessee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
